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A B S T R A C T
The aim of this study was to determine the effect of subminimal inhibitory concentrations (subMICs) of ceftazidime,
meropenem and gentamicin on the in vitro serum sensitivity of Pseudomonas aeruginosa strains isolated from a variety
of isolation sites at two medical wards and an intensive care unit in a government university hospital in Croatia. A total
of 20 serum-resistant P. aeruginosa strains isolated from different clinical specimens were selected. Bacteria were ex-
posed to 1/2, 1/4, 1/8, 1/16, and 1/32 x MIC of each antibiotic tested. Sensitivity of P. aeruginosa strains to bactericidal ac-
tivity of normal human serum before and after bacterial exposure to subMICs was determined. Significant difference in
serum sensitivity of the strains was observed after the bacteria were exposed to subMICs of ceftazidime and meropenem
(p<0.01), while the exposure to subMICs of gentamicin did not affect significantly the resistance of tested strains to the
serum bactericidal activity. Comparing the number of serum-resistant strains before and after exposure to subMICs of
antibiotics, statistically significant differences were determined (p<0.01) after exposure of the strains to 1/2, 1/4, 1/8 and
1/16 x MIC of meropenem, and after exposure to 1/2, 1/4 and 1/8 x MIC of ceftazidime. SubMICs of ceftazidime and
meropenem affected not only the resistance to serum bactericidal activity of bacteria, but also their morphology. The al-
terations in bacterial morphology caused by subMICs of ceftazidime and meropenem could be connected with consecutive
bacterial serum sensitivity.
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Intoduction
Hospitalized patients are particularly susceptible to
Pseudomonas aeruginosa infections and this organism
has emerged as an important nosocomial pathogen dur-
ing the past three decades1. This is partly due to the in-
creased number of patients particularly prone to such in-
fections: immunocompromised patients, patients with
malignancy, cystic fibrosis, burns or traumatic wounds.
Infections with P. aeruginosa is associated with severe
morbidity, and despite antibiotics, lethality to this bacte-
rium is one of the highest among the nosocomial patho-
gens1. P. aeruginosa is responsible for approximately 200
000 nosocomial infections that occur annually2.
Antibiotics are often present at the site of infection at
subinhibitory concentrations, because in human treated
with intermittent dosage schedules of antibiotics, sub-
inhibitory levels will always follow suprainhibitory con-
centrations. Values such as minimal inhibitory concen-
trations (MICs), and serum levels of antibiotics do not
necessarily reflect the situation at the cellular level and,
moreover, antibiotics are often present in subinhibitory
concentrations at sites of infections3. Exposure of bacte-
ria to subminimal inhibitiory concentrations (subMICs)
of diverse antibiotics, although not able to kill bacteria,
can modify their biological characteristics, may cause al-
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teration in bacterial morphology4, proliferation5, also can
modulate bacterial gene expression6, and may interfere
with some essential bacterial functions such as motility
or adhesiveness to different surfaces7,8, etc., thus influ-
encing bacterial virulence. Also, antibiotics act on sus-
ceptible bacteria by modifying their susceptibility to se-
rum antibacterial activity and their interactions with
cellular host defense components9. The increasing num-
ber of immunocompromised patients with infections that
are difficult to treat and the attempt to reduce the prob-
lems of nosocomial infections has stimulated the re-
search for a better understanding of the interactions be-
tween antibiotics and host defense mechanisms, and the
selection of agents with immunostimulatory properties,
which can contribute to recovery of the infection10.
The aim of this research was to determine which of
the studied antibiotics has the best characteristic in or-
der to be capable to affect the serum resistance of P. aeru-
ginosa strains isolated from a variety of isolation sites.
Materials and Methods
Bacterial strains: A total of 20 serum-resistant P.
aeruginosa strains isolated from different specimens (uri-
ne, bronchial secretion, endotracheal and wound aspi-
rates) from patients hospitalized at the Osijek University
Hospital, Osijek, Croatia were selected. Bacteria were
characterized as P. aeruginosa by standard biochemical
procedures and stored in deep-agar tubes at +4 °C (1.5%
nutrient agar, Difco Lab., Detroit, MI, USA) and subcul-
tured by passaging on Trypticase soy agar (TSA, Difco
Lab., Detroit, MI, USA) before use.
Antibiotics and determination of MICs: The MICs of
ceftazidime (Pliva, Zagreb, Croatia), meropenem (Astra
Zeneca, Zagreb, Croatia) and gentamicin (Pliva, Zagreb,
Croatia) were determined for each investigated strain by
standard microdulution method11, by using serial two-
fold dilution of each individual antibiotic in Mueller-Hin-
ton broth medium (Becton Dickinson and Co., Cockeys-
ville MD, USA) in 96-well microtiter plates (Falcon 3077,
Becton Dickinson Labware, New Jersey, USA). MICs
were determined in duplicate and P. aeruginosa strain
ATCC 27853 was included as control. The MICs were de-
fined as the lowest concentrations of antibiotics that in-
hibited the visible growth of bacteria after incubation at
37 °C for 18–24 h.
Exposure of bacteria to subMICs of antibiotics: Bacte-
ria were exposed to 1/2, 1/4, 1/8, 1/16, and 1/32 of MIC of
each antibiotic tested as described previously by Sand-
berg et al.12. In short, a part of one bacterial colony taken
from a Mueller-Hinton agar plate was inoculated in 3 mL
of Mueller-Hinton broth previously distributed in tubes
(approximately 106 bacteria/mL). The tubes were incu-
bated at 37 °C for two hours, at which point the bacteria
were in the logarithmic growth phase. After growth of
the bacteria in tubes for two hours, each antibiotic being
tested was added to test tubes in proportion 1:1 to a final
concentrations of 1/2, 1/4, 1/8, 1/16, and 1/32 ´ MIC, and
Mueller-Hinton broth free of antibiotics was added to the
control cultures. Incubation was then continued for a
further four hours. After the total of six hours of incuba-
tion at 37 °C, the bacteria were harvested by centrifu-
gation (1200 g, 10 min.), and resuspended in phosphate-
-buffered saline (PBS; pH 7.1, 300 mOsmol/L) to a con-
centration of 1.5 ´ 108 cells per mL in PBS.
Serum and serum sensitivity assay: Blood was ob-
tained by venipuncture from three healthy volunteers
and was allowed to clot at room temperature for 30 min.
After centrifugation at 1000 g for 15 min at 4 °C, serum
was removed and pooled. A portion of the pooled serum
was decomplemented by heating at 56 °C for 30 min and
used as test controls. Bacterial susceptibility to serum
killing was measured by assessing regrowth after incuba-
tion in normal human serum according to Schiller and
Hatch method13. Briefly, after adjustment of each bacte-
rial suspension to a concentration equivalent to the con-
centration of 103 bacteria/mL, the mixture of 0.1 mL of
bacterial suspension and 0.1 mL of pooled fresh human
serum were incubated at 37 °C for two hours. Finally, the
percent bacterial survival was determined by plating 0.1
mL samples onto Mueller-Hinton agar plates and the
number of bacteria per milliliter was determined after
incubation at 37 °C for 18–24 hours and compared to con-
trol which contained mixture of bacterial suspension and
decomplemented serum. The bacterial strain was deter-
mined as serum-sensitive if there were more than 90 per-
cent killed bacteria regarded to serum bactericidal activ-
ity. Opposite, if there were less or equal to 90 percent
killed bacteria, bacterial strain was determined as se-
rum-resistant (SR).
Morphological changes of the bacteria: Morphological
changes of bacteria after exposure to subMICs of antibi-
otics were determined by phase-contrast microscopy
(Olympus CX41 microscope, Olympus Optical Co., Ham-
burg, Germany). Any differences from the normal mor-
phological characteristics (shape, damage, filamentation)
were recorded and the overall frequency of their occur-
rence in 100 randomly observed bacteria was deter-
mined. Untreated control organisms appeared as normal
rods approximately 2.5 mm long and 0.6–1 mm wide. Or-
ganisms of up to 15 mm were classified as short filaments
and those longer than 15 mm as long filaments.
Statistical analysis: Proportions were compared by
the c2-test and by Fisher’s exact test when the number in
any of the 2´2 table was 5. P values <0.01 were consid-
ered to be statistically significant.
Results
Serum sensitivity of the 20 P. aeruginosa strains with
or without exposure to subMICs of ceftazidime, merope-
nem and gentamicin is shown in Figures 1, 2, and 3, re-
spectively. Ceftazidime and meropenem increased the se-
rum sensitivity of P. aeruginosa strains in a dose-depen-
dent manner, as is shown in Figures 1 and 2. On the
other hand, such effect was not seen after exposure of
strains to subMICs of gentamicin (Figure 3).
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Significant difference in serum sensitivity of the strains
was observed after the bacteria were exposed to subMICs
of ceftazidime (c2=42.046, DF=5, p<0.01) and merope-
nem (c2=28.687, DF=5, p<0.01), while the exposure to
subMICs of gentamicin did not significantly affect the re-
sistance of investigated strains to the serum bactericidal
activity. Comparing the number of serum-resistant
strains before and after exposure to subMICs of antibiot-
ics, statistically significant differences were determined
(p<0.01) after exposure of the strains to 1/2, 1/4, 1/8 and
1/16 ´ MIC of meropenem, and after exposure to 1/2, 1/4
and 1/8 ´ MIC of ceftazidime (Table 1).
As was shown by phase-contrast microscopy, subMICs
of antibiotics altered not only susceptibility of bacteria to
serum killing but also their morphology. Morphological
changes were most prominent after bacterial exposure to
1/2, 1/4, and 1/8 ´ MIC of ceftazidime and meropenem.
Higher concentrations of those antibiotics caused forma-
tion of very long filaments, which measured up to 30 mm.
After incubation with ceftazidime at higher concentra-
tions virtually all of the P. aeruginosa cells altered to a fil-
amentous morphology. Moreover, higher concentrations
of meropenem beside filamentous forms of bacterial cells,
caused also the formation of irregular swellings of such
filaments and formation of spheroplast-like structures,
as are shown in Figure 4. The length of filaments de-
creased as the concentration of antibiotics was being re-
duced and at concentrations of 1/16 and 1/32 ´ MIC only
short filaments were observed. SubMICs of gentamicin
did not affect the bacterial morphology.
Discussion
Serum bactericidal activity has been regarded as one
of the most important host defense mechanisms against
bacterial infections14. It is known that invasive bacterial
pathogens are commonly very resistant to serum bacteri-
cidal activity15–18, and it appears that serum resistance is
an important virulence factor of invasive bacteria. Al-
though, precise mechanisms of bacterial resistance to a
serum bactericidal activity is not known yet, it is known
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Fig. 1. Effect of subMICs of ceftazidime on serum sensitivity of
the strains. MIC – minimal inhibitory concentrations.
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Fig. 2. Effect of subMICs of meropenem on serum sensitivity of
the strains. MIC – minimal inhibitory concentration.
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Fig. 3. Effect of subMICs of gentamicin on serum sensitivity of
the strains. MIC – minimal inhibitory concentration.
TABLE 1
EFFECT OF SUBINHIBITORY CONCENTRATIONS OF
ANTIBIOTICS ON SERUM SENSITIVITY OF 20 SERUM
RESISTANT STRAINS
Antibiotics
No. of
SRa Strains
p-value
Ceftazidime 1/2´MIC 4 7.709 ´ 10–8
1/4´MIC 7 6.442 ´ 10–6
1/8´MIC 7 6.442 ´ 10–6
1/16´MIC 14 0.0101
1/32´MIC 17 0.1154
Meropenem 1/2´MIC 5 3.854 ´ 10–7
1/4´MIC 7 6.442 ´ 10–6
1/8´MIC 9 7.265 ´ 10–5
1/16´MIC 12 1.638 ´ 10–3
1/32´MIC 13 0.0415
Gentamicin 1/2´MIC 17 0.1154
1/4´MIC 18 0.2436
1/8´MIC 18 0.2436
1/16´MIC 18 0.2436
1/32´MIC 19 0.5000
a Number of serum-resistant (SR) strains after expossure of 20
SR strains to subminimal inhibitory concentrations (subMICs)
of antibiotics
that such mechanisms include alterations of bacterial
surface, which interfere with activation, or function of
complement19–21. As expected, most strains of P. aerugi-
nosa isolated from blood, wounds, urine, or burns are re-
sistant to the bactericidal activity of normal human
serum13, and Schiller and Joiner suggested that serum
resistance of P. aeruginosa does not represent a failure to
activate complement, but instead reflects a failure of the
assembled terminal complement complex C5b-9 to insert
into the outer membrane of the strain22. The results of
the present study indicated that the alterations in P.
aeruginosa morphology caused by subMICs of ceftazi-
dime and meropenem were associated with the consecu-
tive bacterial sensitivity to serum bactericidal activity of
diluted human sera. Altered cell surface characteristics
of ceftazidime- and meropenem-treated bacteria may in-
crease the bactericidal action of antibody and comple-
ment. Further studies are necessary to investigate the ef-
fects of subMICs of ceftazidime and meropenem on the
molecular changes of P. aeruginosa cell wall components,
such as expression of fimbriae, the structure and amount
of outer membrane proteins and lipopolysaccharides, or
other factors responsible for enhanced serum sensitivity.
Filament formation following the treatment of P. ae-
ruginosa and other gram-negative bacilli with subMICs
of various â-lactam antibiotics has been previously des-
cribed23–25. This probably represents the preferential bin-
ding of those antibiotics to penicillin binding protein 3,
which is required for the synthesis of peptidoglycan for
cross walls, but not for side walls. Those studies indi-
cated that the filaments produced at subinhibitory con-
centrations of antibiotics were devoid of fimbriae and
ability to adhere to epithelial cells24,25.
Other authors also reported that subMICs of antibiot-
ics interfered with the pathogenic potential of P. aerugi-
nosa. Fonesca et al. observed that the change in bacterial
morphology and hydrophobicity caused by subinhibitory
concentrations of piperacillin-tazobactam was associated
with a significant decrease in the adherence ability, mo-
tility and biofilm formation of P. aeruginosa strains23.
Garske et al. showed that subinhibitory concentrations
of ceftazidime and tobramycin reduced the quorum sens-
ing signals of P. aeruginosa26. On the contrary, recent
study showed that subinhibitory concentrations of ami-
noglycoside antibiotics induced biofilm formation in P.
aeruginosa and Escherichia coli27.
Conclusion
Significant difference in serum sensitivity of the bac-
teria was observed after the serum-resistant P. aerugino-
sa strains were exposed to subMICs of ceftazidime and
meropenem, while the exposure to subMICs of genta-
micin did not affect significantly the resistance of tested
strains to the serum bactericidal activity. The bacterial
sensitivity to serum bactericidal activity after exposure
of strains to subMICs of ceftazidime and meropenem cor-
related with the alterations in bacterial cell morphology.
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UTJECAJ SUBINHIBICIJSKIH KONCENTRACIJA CEFTAZIDIMA I MEROPENEMA
NA IN VITRO OSJETLJIVOST NA BAKTERICIDNU AKTIVNOST SERUMA SOJEVA
PSEUDOMONAS AERUGINOSA
S A @ E T A K
Svrha istra`ivanja bila je odrediti djelovanje subminimalnih inhibicijskih koncentracija (subMIK) ceftazidima, me-
ropenema i gentamicina na in vitro osjetljivost na baktericidnu aktivnost seruma sojeva Pseudomonas aeruginosa izo-
liranih iz razli~itih materijala u dva odjela te u jedinici intenzivnog lije~enja jedne hrvatske klini~ke bolnice. Odabrano
je 20 serum-rezistentnih sojeva P. aeruginosa izoliranih iz razli~itih klini~kih uzoraka. Bakterije su izlagane koncen-
traciji od 1/2, 1/4, 1/8, 1/16 i 1/32 MIK-a svakog od istra`ivanih antibiotika. Odre|ena je osjetljivost sojeva P. aeruginosa
na baktericidnu aktivnost ljudskog seruma prije i nakon izlaganje bakterija subMIK-ovima. Opa`ena je zna~ajna raz-
lika u serumskoj osjetljivosti sojeva nakon {to su bakterije izlo`ene subMIK-ovima ceftazidima i meropenema, dok
izlaganje subMIK-ovima gentamicina nije zna~ajno utjecalo na otpornost istra`ivanih sojeva na baktericidnu aktivnost
seruma. Uspore|uju}i broj serum-rezistentnih sojeva prije i nakon izlaganja subinhibicijskim koncentracijama antibio-
tika, uo~ena je statisti~ki zna~ajna razlika (p<0,01) nakon izlaganja sojeva koncentracijama od 1/2, 1/4, 1/8 i 1/16 MIK-a
meropenema, te 1/2, 1/4 i 1/8 MIK-a ceftazidima. Subinhibicijske koncentracije ceftazidima i meropenema nisu samo
utjecale na rezistenciju bakterija na baktericidnu aktivnost seruma, ve} i na njihovu morfologiju. Promjene bakterijske
morfologije izazvane subMIK-ovima ceftazidima i meropenema mogle bi biti povezane s posljedi~nom bakterijskom
osjetljivo{}u na baktericidnu aktivnost seruma.
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